Navigation Links
Video: Waters Highlights Impact of ACQUITY UPLC with Peer-to-Peer Scientist Testimonials
Date:4/24/2009

ACQUITY UltraPerformance Liquid Chromatography is Proven, Reliable, and Robust

MILFORD, Mass., April 24 /PRNewswire-FirstCall/ -- Waters Corporation (WAT:NYSE) today released the latest of dozens of scientist testimonials highlighting the impact of Waters(R) ACQUITY UltraPerformance LC(R) (UPLC(R)) on laboratory science. Five years ago, Waters introduced the ACQUITY(R) UPLC total system solution designed to maximize sub-2 micron chemistries and high-pressure instrumentation. Today, thousands of laboratories worldwide use ACQUITY UPLC as the technology is proven, reliable, and robust.

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/waters/37947/

"In recent years, [the most significant new development] in analytical chemistry has been the development of UltraPerformance Liquid Chromatography, which was pioneered by Waters," said, Prof. Jeremy Nicholson, Chair Biological Chemistry, Imperial College, London. "When you couple that to a time-of-flight mass spectrometer you have an incredibly powerful tool capable of measuring hundreds or thousands of molecules at the same time, in one sample in one analytical run."

Additional examples of UPLC impact include:

  • To date, there have been more than 400 peer-reviewed papers published using ACQUITY UPLC, with another 300 application notes available in Waters on-line library.
  • Through its recent introduction of Phase II ACQUITY UPLC Columns, Waters family of ACQUITY UPLC columns now includes three UPLC particle substrates, eleven bonded phases in over one hundred UPLC column configurations, and VanGuard(TM) Pre-Columns.
  • Lastly, thousands of scientists participate in a vibrant on-line community exclusively for UPLC users.

Waters ACQUITY UPLC System received a Gold Pittcon Editors Award for a new product at the 2004 Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy, the industry's premier conference and exhibition.

For more information on ACQUITY UPLC, please visit: www.waters.com/waters/nav.htm?locale=en_US&cid=514207

About Waters Corporation (www.waters.com)

For 50 years, Waters Corporation (NYSE: WAT) creates business advantages for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide.

Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.

With revenue of $1.58 billion in 2008 and 5,000 employees, Waters is driving scientific discovery and operational excellence for customers worldwide.

Waters, ACQUITY, UltraPerformance Liquid Chromatography, UPLC, and VanGuard are trademarks of Waters Corporation.

    Press Contact:
    Brian Murphy
    Waters Corporation
    Corporate Public Relations
    brian_j_murphy@waters.com
    508-482-2614

'/>"/>
SOURCE Waters Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Video: Nutrition Comes to NASCAR
2. Video: Circulatory Care of New Jersey
3. Video: GEN Video Hits Home with Web Audience
4. Video: Beyond the Red Door: Gildas Club Worldwide and DKNY Host Successful Benefit Event
5. Video: Food Expert B. Smith to Provide Healthy Menu Makeovers
6. Video: New FDA-Approved Sun Protectant Saves Skin All Year Round
7. Video: Kyphon Supports World Osteoporosis Day on October 20, 2007 to Raise Awareness of Osteoporosis and Spinal Fracture Risk
8. Video: Trinity Mother Frances Neurosurgeon First in Region to Remove Brain Tumor Using Unique Surgical Procedure
9. Video: Holiday Safety Is Important
10. Video: Grin Big With an Award-Winning Smile
11. Video: BSP Pharma Inc. Announces Groundbreaking Findings from The Australian Centre for Complementary Medicine Education and Research Joint Health Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... Vancouver, British Columbia (PRWEB) , ... June 28, ... ... (OTCQB: CNZCF) (FSE: ZEON) is pleased to announce that a two year study ... using the Company's Bromley Creek zeolite was successful in remediating potash brine-impacted groundwater. ...
(Date:6/28/2017)... , ... June 28, 2017 , ... ... firm servicing communities throughout the greater Cincinnati metropolitan area, is teaming up with ... lodgings for families with children receiving treatment in nearby hospitals. , Ronald McDonald ...
(Date:6/27/2017)... Zurich, Switzerland (PRWEB) , ... June 27, 2017 , ... ... crowd to manage token assets on the Ethereum blockchain, has released their technical ... but until now, there has been little systematic approach for determining which offerings will ...
(Date:6/27/2017)... (PRWEB) , ... June 27, 2017 , ... From June ... The three-day event was held in Syracuse, New York, where EarQ is headquartered. , ... industry, how to connect with today’s savvy consumer, and the latest in hearing ...
(Date:6/27/2017)... ... June 27, 2017 , ... ... to an upcoming case studies guidebook. This guidebook offers an excellent branding and ... will include articles, case studies and how-to’s that fall into the following categories:, ...
Breaking Medicine News(10 mins):
(Date:6/11/2017)... INDIANAPOLIS , June 10, 2017  Eli Lilly and ... results from three Phase 3 studies of galcanezumab, an ... migraine, including late-breaking data on several key secondary endpoints ... Detailed results from these studies (EVOLVE-1, EVOLVE-2 and REGAIN) ... (AHS) annual scientific meeting in Boston ...
(Date:6/9/2017)... INDIANAPOLIS , June 9, 2017 ... In a further effort to help spread lessons learned ... condition, the International Diabetes Federation (IDF) and Eli Lilly ... together for the second phase of the Bringing Research ... 2), reaffirming their commitment to helping people with diabetes ...
(Date:6/8/2017)... , June 8, 2017  StatLab Medical ... developer and manufacturer of diagnostic supplies for ... that Cressey & Company LP ("Cressey & ... completed a growth-focused investment in the Company. ... ownership position from selling shareholder, Prairie Capital, ...
Breaking Medicine Technology: